2026 NPPES data Hematology & Oncology Physician NPI 1588654842 APRN
Verify on CMS →

MELISSA CETAK, APRN

Hematology & Oncology Physician in LINCOLN, Nebraska. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
520
Medicare Part D claims · 192 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
73.6817/100
▼ 9 pts below national avg 83.1 · [object Object]
Industry payments
$1.3K
69 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MELISSA CETAK, APRN is a Hematology & Oncology Physician ([object Object]) practicing in LINCOLN, Nebraska with a Medicare Part D prescribing footprint of 520 claims across 192 beneficiaries — 13% brand-name prescribing . Their CMS MIPS Final Score of 73.6817/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $1.3K across 69 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MELISSA CETAK, APRN reported a CMS MIPS final score of 73.6817 out of 100, below the 83.1 national average, and filed 520 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MELISSA CETAK, APRN practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MELISSA CETAK, APRN at a glance

Below national average

NPI registry status

Active

Issued 10/26/2005

NPI 1588654842

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

520 39% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

73.6817/100 9.418299999999988% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Nebraska

How Hematology & Oncology Physician compares to other specialties among Nebraska providers

Nebraska providers

Hematology & Oncology Physician share within Nebraska

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Nebraska

Medicare quality performance — MIPS

MELISSA CETAK, APRN's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
73.6817/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 73.6817/100 vs national avg 83.1

0%100%National avg83%73.7%
MIPS final score (Hematology & Oncology Physician) — 73.6817/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MELISSA CETAK, APRN is a Hematology & Oncology Physician provider practicing in LINCOLN, Nebraska, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: APRN. NPI: 1588654842. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MELISSA CETAK, APRN appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding APRN credentials at 4101 TIGER LILY RD STE 100, LINCOLN, NE, 68516, with a listed phone of (402) 420-7000. NPI 1588654842 was issued on 10/26/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CETAK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 520 prescription claims written by this provider, covering 192 Medicare beneficiaries and totaling roughly $739K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 9.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 73.6817/100 for the 2023 performance year (Quality 86.3876, Cost 37.0295), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4101 TIGER LILY RD STE 100
LINCOLN, NE 68516

Provider Details

NPI 1588654842
Specialty Hematology & Oncology Physician
Credentials APRN
Gender Female
NPI Issued 10/26/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

73.6817
Final Score
Avg: 83.1
86.3876
Quality
37.0295
Cost
82
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MELISSA CETAK, APRN. Source: openpaymentsdata.cms.gov.

Total received

$1.3K

Largest payer

Janssen Biotech, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MELISSA CETAK, APRN — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 520 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

520
Total Claims
$739K
Total Drug Cost
192
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
592
Total Day Supply
11,438
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$714K
Generic Drug Cost
$25K
Opioid Claims
48 (9.2% rate)
Antibiotic Claims
41

Patient Demographics

Average Patient Age
72.4 years
Avg HCC Risk Score
2.52
Gender Split
54% female / 46% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ondansetron Hcl
37
Prednisone
36
Diphenoxylate-Atropine
Diphenoxylate Hcl/Atropine
34
Potassium Chloride
31
Acyclovir
27
Dexamethasone
23
Prochlorperazine Maleate
23
Anastrozole
17
Imatinib Mesylate
17
Imbruvica
Ibrutinib
16

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How MELISSA CETAK, APRN fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

MELISSA CETAK, APRN's 520 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Nebraska

Other clinicians with the same primary specialty enrolled in Nebraska, drawn from the same CMS NPPES roster as CETAK.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MELISSA CETAK, APRN's specialty?
MELISSA CETAK, APRN specializes in Hematology & Oncology Physician and practices in LINCOLN, Nebraska. Credentials: APRN.
How much does MELISSA CETAK, APRN prescribe under Medicare Part D?
In 2023, MELISSA CETAK, APRN wrote 520 Medicare Part D claims totaling $739K in drug costs for 192 beneficiaries.
What is MELISSA CETAK, APRN's Medicare quality score?
MELISSA CETAK, APRN has a CMS MIPS Final Score of 73.6817/100 (Quality: 86.3876, Cost: 37.0295). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MELISSA CETAK, APRN located?
MELISSA CETAK, APRN is located at 4101 TIGER LILY RD STE 100, LINCOLN, NE, 68516. Phone: (402) 420-7000.
What is MELISSA CETAK, APRN's NPI number?
MELISSA CETAK, APRN's National Provider Identifier (NPI) is 1588654842, issued on 10/26/2005.
Does MELISSA CETAK, APRN prescribe more brand-name or generic drugs?
MELISSA CETAK, APRN's prescribing is 13% brand-name and 87% generic drugs by claim count, with $714K in brand drug costs.
Does MELISSA CETAK, APRN prescribe opioids?
Yes, MELISSA CETAK, APRN had 48 opioid claims in 2023 with an opioid prescribing rate of 9.2%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does MELISSA CETAK, APRN prescribe most often?
Based on 2023 Medicare Part D data, MELISSA CETAK, APRN's most frequently prescribed drugs include Ondansetron Hcl, Prednisone, Diphenoxylate-Atropine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MELISSA CETAK, APRN accept Medicare?
MELISSA CETAK, APRN appears in CMS Medicare data with 520 Part D claims and 192 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MELISSA CETAK, APRN's credentials?
MELISSA CETAK, APRN's NPI is 1588654842 with credentials APRN. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology